UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 310

Sortiert nach

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Gene therapy, 2019-09, Vol.26 (9), p.363-372

2019

Volltextzugriff (PDF)

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

Nature communications, 2020-07, Vol.11 (1), p.3523-7, Article 3523

2020

Volltextzugriff (PDF)

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

Frontiers in immunology, 2020-12, Vol.11, p.608460-608460

2020

Volltextzugriff (PDF)

Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice

PloS one, 2012-12, Vol.7 (12), p.e50529-e50529

2012

Volltextzugriff (PDF)

Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines

Journal of controlled release, 2021-10, Vol.338, p.201-210

2021

Volltextzugriff (PDF)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Nature communications, 2021-05, Vol.12 (1), p.2893-2893, Article 2893

2021

Volltextzugriff (PDF)

Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Journal of translational medicine, 2011-01, Vol.9 Suppl 1 (S1), p.S6-S6, Article S6

2011

Volltextzugriff (PDF)

Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae

The Journal of immunology (1950), 2020-02, Vol.204 (4), p.903-913

2020

Volltextzugriff (PDF)

Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA

Molecular therapy, 2021-03, Vol.29 (3), p.1174-1185

2021

Volltextzugriff (PDF)

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Vaccines (Basel), 2020-12, Vol.9 (1), p.3

2020

Volltextzugriff (PDF)

Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer

ACS nano, 2020-05, Vol.14 (5), p.5711-5727

2020

Volltextzugriff (PDF)

HIV vaccine research in Canada

AIDS research and therapy, 2017-09, Vol.14 (1), p.54-54, Article 54

Shattock, Robin

2017

Volltextzugriff (PDF)

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines

PLoS pathogens, 2022-10, Vol.18 (10), p.e1010885-e1010885

2022

Volltextzugriff (PDF)

Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9

Journal of general virology, 2015-08, Vol.96 (8), p.2381-2393

2015

Volltextzugriff (PDF)

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

The Lancet infectious diseases, 2019-10, Vol.19 (10), p.1091-1100

2019

Volltextzugriff (PDF)

One Size Does Not Fit All: The Effect of Chain Length and Charge Density of Poly(ethylene imine) Based Copolymers on Delivery of pDNA, mRNA, and RepRNA Polyplexes

Biomacromolecules, 2018-07, Vol.19 (7), p.2870-2879

2018

Volltextzugriff (PDF)

Neutrophils Enable Local and Non‐Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic Heart

Advanced materials (Weinheim), 2020-12, Vol.32 (48), p.e2003598-n/a

2020

Volltextzugriff (PDF)

Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery

Biomacromolecules, 2023-11, Vol.24 (11), p.5142-5151

2023

Volltextzugriff (PDF)

Learning from crisis: building resilient systems to combat future pandemics

The Lancet (British edition), 2021-07, Vol.398 (10294), p.e2-e6

2021

Volltextzugriff (PDF)

Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice

Nature communications, 2024-02, Vol.15 (1), p.1665-1665, Article 1665

2024

Volltextzugriff (PDF)

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

PloS one, 2016-01, Vol.11 (1), p.e0143109-e0143109

2016

Volltextzugriff (PDF)

Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways

PLoS pathogens, 2017-09, Vol.13 (9), p.e1006577-e1006577

2017

Volltextzugriff (PDF)

Inhibiting sexual transmission of HIV-1 infection

Nature reviews. Microbiology, 2003-10, Vol.1 (1), p.25-34

2003

Volltextzugriff (PDF)

Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA

Journal of controlled release, 2019-06, Vol.304, p.65-74

2019

Volltextzugriff (PDF)

Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants

Journal of controlled release, 2021-02, Vol.330, p.1250-1261

2021

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(203)
Humans
(173)
Immunology
(104)
Female
(103)
Human Immunodeficiency Virus
(92)
Animals
(89)
Hiv
(82)
Virology
(78)
Vaccines
(71)
Human Immunodeficiency Virus 1
(69)
Infectious Diseases
(64)
Hiv Infections - Prevention & Control
(58)
Microbiology
(56)
Biological And Medical Sciences
(54)
Male
(47)
Infections
(45)
Hiv-1
(44)
Medicine, Research & Experimental
(40)
Research & Experimental Medicine
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(29)
Journal Of Virology
(19)
Aids
(14)
Vaccine
(13)
Frontiers In Immunology
(12)
Journal Of Controlled Release
(10)
Plos Pathogens
(8)
Retrovirology
(8)
The Journal Of Immunology
(8)
Antimicrobial Agents And Chemotherapy
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice

Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae

Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer

HIV vaccine research in Canada

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines

Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

One Size Does Not Fit All: The Effect of Chain Length and Charge Density of Poly(ethylene imine) Based Copolymers on Delivery of pDNA, mRNA, and RepRNA Polyplexes

Neutrophils Enable Local and Non‐Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic Heart

Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery

Learning from crisis: building resilient systems to combat future pandemics

Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways

Inhibiting sexual transmission of HIV-1 infection

Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA

Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants

Suchergebnisse filtern